NeoVax With Nivolumab in Patients With Ovarian Cancer

NCT04024878 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Nivolumab
BIOLOGICAL: NeoVax
PROCEDURE: Core Needle Biopsy

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]